EDSA 2.2 (+0.46%)
CA27966L1085BiotechnologyBiotechnology

Edesa Biotech (EDSA) Stock Highlights

2.2 | +0.46%
2024-11-21 06:37:17
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The companys product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The companys EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.

Statistics

Range Today
2.05 2.24
Volume Today 11K
Range 1 Year
2.09 6.46
Volume 1 Year 4.46M
Range 3 Year
2.09 47.6
Volume 3 Year 19.47M
Range 10 Year
2.09 4351.2
Volume 10 Year 86.18M

Highlights

Market Capitalization 7.86M (micro)
Floating Shares 2.44M
Current Price 2.2
Price To Earnings -0.13
Price To Book 2.74
Earnings Per Share -19.78
Payout Ratio 0%

Performance

Latest +0.46%
1 Month -46.6%
3 Months -50.56%
6 Months -51.33%
1 Year -25.42%
3 Years -95.28%
5 Years -93.64%
10 Years -99.95%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.